CIN2 | CIN3-CIS | CIN2–3 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Method | Women age (years) | HPV 16/18 (%) | HPV 31/33/45/52/58 (%) | p | HPV 16/18 (%) | HPV 31/33/45/52/58 (%) | p | HPV 16/18 (%) | HPV 31/33/45/52/58 (%) | p |
Minimum estimate | 18–34 | 64 | 25 | 71 | 14 | * | 69 | 17 | * | |
35–44 | 52 | 39 | 68 | 13 | 62 | 22 | * | |||
≥45 | 33 | 33 | 52 | 24 | 45 | 27 | * | |||
p-trend | * | |||||||||
Proportional attribution | 18–34 | 53 | 29 | * | 74 | 13 | * | 66 | 19 | * |
35–44 | 48 | 41 | * | 64 | 16 | * | 59 | 24 | * | |
≥45 | 48 | 26 | 44 | 28 | * | 46 | 27 | * | ||
p-trend | * | * | ||||||||
Hierarchical attribution | 18–34 | 63 | 23 | * | 78 | 12 | * | 72 | 16 | * |
35–44 | 51 | 40 | * | 66 | 19 | * | 62 | 26 | * | |
≥45 | 50 | 25 | 45 | 32 | * | 47 | 29 | * | ||
p-trend | * | * |